Ab&B Bio-Tech's Hong Kong IPO Sparks 170% Surge in Shares
Ab&B Bio-Tech's IPO in Hong Kong saw its stock soar over 169% on debut, driven by strong retail investor demand for its influenza vaccine and other health products, marking a successful entry amid a rally in healthcare stocks.